IVD

Abbott’s FreeStyle Libre Catches Sanofi’s Eye in New Collaboration

Paris-based Sanofi will work with Abbott Laboratories to integrate glucose sensing and insulin delivery technologies to help improve diabetes management in patients. Abbott’s Freestyle Libre – a device that brought in $430 million in revenue for 2Q19, will be at the heart of the collaboration.

OncoCell MDx Rides the Liquid Biopsy Wave with New Financing

The Royal Oak, MI-based company has raised $22.2 million in a series B round and is developing a test for the detection of prostate cancer. Executives from OncoCell said the test could be available late next year.

OncoCyte Spells Out the Acquisition Plan for Razor Genomics

The Alameda, CA-based company said the deal could help it boost its lung cancer detection offerings.

A Young Biotech Company Garners Australian Design Award for Innovative Diagnostics

A portable device and inexpensive cartridges are designed to deliver quick and accurate diagnoses of infectious diseases without the need for a clinical laboratory.

Could Open-Access Diagnostics Speed Diagnoses?

LexaGene's automated screening technology for 22 known pathogens may also be able to help identify an unknown one.

Separating Plasma from Smaller and Smaller Blood Samples

Sample sizes of whole blood are reportedly shrinking. Can a biochemically enhanced material help diagnostic device designers separate enough plasma to support new testing efforts?

Study Finds Abbott’s Blood Test More Successful in Detecting TBI than CT Scans

The Abbott Park, IL-based company's test, which is still in development, was evaluated in the TRACK-TBI study.

Understanding Sodium Azide

A few tips on handling the diagnostic reagent preservative safely.

Abbott Targets Drug and Alcohol-Impaired Drivers in New Collaboration

Intoximeters will market its alcohol testing products along with Abbott’s SoToxa Mobile Test System – a handheld oral fluid roadside testing solution that detects recent drug use.

Supplier Stories for the Week of August 11

Here’s what was new in the world of medical device suppliers during the week of August 11.

Roche Expands Global Access to Viral Assays to Aid Eradication Efforts

Access to diagnostic assays is key to achievement of the World Health Organization’s infectious disease elimination goals.

Guardant Brings Home Strong Results as Liquid Biopsy Space Heats Up

The Redwood City, CA-based company said results of a study show the Guardant360 liquid biopsy assay can accurately detect microsatellite instability status as accurately as tissue biopsy.

LFI Devices: 3 Reasons for OEMs and Developers to Consider Automation

There is a compelling case to leverage automation in lateral flow immunoassay device manufacturing, and the top reasons may surprise you.

Exact Sciences and Genomic Health Merge to become Diagnostics Titan

Exact Sciences said it will acquire Redwood City, CA-based Genomic Health for $72 per share in a cash stock transaction valued at $2.8 billion, in a deal set to close by the end of the year.

How a New Sensor Could Diagnose Sepsis in 25 Minutes

MIT researchers designed a sensor that could dramatically accelerate the process of diagnosing sepsis, a leading cause of death in U.S. hospitals.

Top 9 Companies in the Diagnostics Market

The diagnostics space has been filled with market clearances; collaborations and a dash of M&A. MD+DI has compiled a list of the most influential companies in the market.

Qmed Search Form